Results 151 to 160 of about 353,788 (280)

From first seizure to specific antiseizure medication in Dravet syndrome: Quantifying delays in the DS'coverED study. [PDF]

open access: yesEpilepsia Open
Christodoulou L   +9 more
europepmc   +1 more source

EEG reveals what the eyes can't see: A clinical vignette of epileptic visual loss

open access: yes
Epileptic Disorders, EarlyView.
Zoi Kallia   +5 more
wiley   +1 more source

WONOEP appraisal: Biomarkers and treatment strategies beyond the synapse

open access: yesEpilepsia, EarlyView.
Abstract Epilepsy is a heterogeneous neurological disorder affecting more than 70 million people worldwide, posing significant challenges for clinicians due to its complex etiology, diverse manifestations, variable treatment responses, and the inability to predict seizures or disease onset reliably.
Mirte Scheper   +11 more
wiley   +1 more source

Did the French pregnancy pictogram change antiseizure medication use during pregnancy? [PDF]

open access: yesEpilepsia
Araujo M   +7 more
europepmc   +1 more source

Temporal lobe epilepsy with bilateral amygdala enlargement mimicking behavioral variant frontotemporal dementia

open access: yes
Epileptic Disorders, EarlyView.
Kentaro Tokumoto   +7 more
wiley   +1 more source

New onset refractory status epilepticus (NORSE) versus refractory status epilepticus not meeting NORSE criteria: A comparative clinical and electroencephalography‐based study

open access: yesEpilepsia, EarlyView.
Abstract Objective New onset refractory status epilepticus (NORSE) is a rare, severe presentation of refractory status epilepticus (RSE), with approximately half of cases cryptogenic NORSE (c‐NORSE). We compared electroencephalographic (EEG) findings alongside clinical features between NORSE and RSE not meeting NORSE criteria to better understand ...
Seren Hawksworth   +6 more
wiley   +1 more source

Cardiovascular events and mortality in adults with late onset seizures: Focus on enzyme‐modulating antiseizure medications

open access: yesEpilepsia, EarlyView.
Abstract Objective Using a Dutch insurance claims registry, we examine whether people with epilepsy have an increased risk of major ischemic cardiovascular events or death compared to people without epilepsy. We also assess whether this risk differs between users of enzyme‐modulating and non‐enzyme‐modulating antiseizure medications (ASMs).
Paola Vassallo   +4 more
wiley   +1 more source

Treatment Patterns of Antiseizure Medication for Poststroke Prophylaxis Among Older Adults. [PDF]

open access: yesJ Am Heart Assoc
Sun S   +6 more
europepmc   +1 more source

Seizure forecasting: The long and winding road to clinical translation

open access: yesEpilepsia, EarlyView.
Abstract Seizure forecasting has progressed from theoretical aspiration to a rapidly advancing research domain, yet clinical translation remains limited. Over the past decades, advances in algorithm development, chronic electroencephalography (EEG), wearable sensors, and the characterization of seizure cycles have demonstrated that seizure risk is not ...
Philippa J. Karoly   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy